Point72 Hong Kong LTD Verastem, Inc. Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $7,529 - $14,916	-7,103 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $14,561 - $22,729	7,103 New	7,103 $15,000
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $932 - $1,760	-363 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.9 - $2.82 $689 - $1,023	363 New	363 $1,000
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $5,997 - $12,516	-5,215 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$1.11 - $1.68 $5,788 - $8,761	5,215 New	5,215 $6,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $4,733 - $11,891	-3,787 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.79 - $4.09 $10,565 - $15,488	3,787 New	3,787 $11,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.22B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.